These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9625811)

  • 21. Stable expression of temperature-sensitive p53: a suitable model to study wild-type p53 function in pancreatic carcinoma cells.
    Nuevemann D; Christgen M; Ungefroren H; Kalthoff H
    Oncol Rep; 2006 Sep; 16(3):575-9. PubMed ID: 16865258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of Ewing tumor cells to forced and activated p53 expression.
    Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
    Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
    Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells.
    Pulukuri SM; Rao JS
    Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells.
    Blandino G; Scardigli R; Rizzo MG; Crescenzi M; Soddu S; Sacchi A
    Oncogene; 1995 Feb; 10(4):731-7. PubMed ID: 7862450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Michalovitz D; Halevy O; Oren M
    Cell; 1990 Aug; 62(4):671-80. PubMed ID: 2143698
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ezerskyte M; Paredes JA; Malvezzi S; Burns JA; Margison GP; Olsson M; Scicchitano DA; Dreij K
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4731-4736. PubMed ID: 29666243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
    Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
    Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells.
    Cascalló M; Mercadé E; Capellà G; Lluís F; Fillat C; Gómez-Foix AM; Mazo A
    Cancer Gene Ther; 1999; 6(5):428-36. PubMed ID: 10505853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
    Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
    Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion.
    Knippschild U; Oren M; Deppert W
    Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
    Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
    EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
    Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
    Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality.
    Johnson TM; Hammond EM; Giaccia A; Attardi LD
    Nat Genet; 2005 Feb; 37(2):145-52. PubMed ID: 15654339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
    Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
    Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.
    Robles AI; Bemmels NA; Foraker AB; Harris CC
    Cancer Res; 2001 Sep; 61(18):6660-4. PubMed ID: 11559530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53.
    Woo RA; Jack MT; Xu Y; Burma S; Chen DJ; Lee PW
    EMBO J; 2002 Jun; 21(12):3000-8. PubMed ID: 12065413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
    Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
    Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.